Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan.
Saved in:
| Title: | Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan. |
|---|---|
| Authors: | Li C; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Yu D; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Wu X; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Liang H; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Zhou Z; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Xie Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Li T; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Wu J; Chengdu Rongsheng Pharmaceuticals Co., Ltd, Chengdu, China., Lu F; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Feng L; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Mao M; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Lin L; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Guo H; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Yue S; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Wang F; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Peng Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Hu Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Wang Z; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China., Yu J; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Zhang Y; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Lu J; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China., Ning H; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Yang H; China National Biotec Group Company Limited, Beijing, China., Fu D; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., He Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China.; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Zhou D; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Du T; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Duan K; Wuhan Institute of Biological Products Co. Ltd, Wuhan, China., Dong D; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Deng K; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Zou X; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Zhang Y; Sinopharm Wuhan Plasma-derived Biotherapies Co., Ltd, Wuhan, China., Zhou R; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Gao Y; Beijing Tiantan Biological Products Co., Ltd, Beijing, China., Zhang X; Research Laboratory of Clinical Virology, Ruijin Hospital and Ruijin Hospital North, National Research Center for Translational Medicine, Shanghai Jiao Tong University of Medicine, Shanghai, China. zhangx@shsmu.edu.cn., Yang X; China National Biotec Group Company Limited, Beijing, China. yangxiaoming@sinopharm.com. |
| Source: | Nature communications [Nat Commun] 2021 Aug 05; Vol. 12 (1), pp. 4846. Date of Electronic Publication: 2021 Aug 05. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-021-25109-1 |
